Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers

BACKGROUND: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize effectiveness in those previously exposed to SARS-CoV-2 and what other factors affect responsiveness. METHODS: We measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Moncunill, Gemma, Aguilar, Ruth, Ribes, Marta, Ortega, Natalia, Rubio, Rocío, Salmerón, Gemma, Molina, María José, Vidal, Marta, Barrios, Diana, Mitchell, Robert A., Jiménez, Alfons, Castellana, Cristina, Hernández-Luis, Pablo, Rodó, Pau, Méndez, Susana, Llupià, Anna, Puyol, Laura, Rodrigo Melero, Natalia, Carolis, Carlo, Mayor, Alfredo, Izquierdo, Luis, Varela, Pilar, Trilla, Antoni, Vilella, Anna, Barroso, Sonia, Angulo, Ana, Engel, Pablo, Tortajada, Marta, García-Basteiro, Alberto L., Dobaño, Carlota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752368/
https://www.ncbi.nlm.nih.gov/pubmed/35032961
http://dx.doi.org/10.1016/j.ebiom.2021.103805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752368/
https://www.ncbi.nlm.nih.gov/pubmed/35032961
http://dx.doi.org/10.1016/j.ebiom.2021.103805

Ejemplares similares